The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Abstract
Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcription-dependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of colorectal cancer by induction of ferroptosis.
MeSH terms
Funding
- American Cancer Society
- Association pour la Recherche sur le Cancer
- Johns Hopkins University
- European Commission
- Fondation Leducq
- National Natural Science Foundation of China
- Fondation pour la Recherche Médicale
- Natural Science Foundation of Guangdong Province
- Ligue Contre le Cancer
- Institut Universitaire de France
- Institut National Du Cancer
- Cancéropôle Ile de France
- Guangdong Science and Technology Department
- National Institutes of Health
- Cancer Institute, University of Pittsburgh
- H2020 European Research Council
How this paper connects to the literature. Drag to explore, click any node to open that paper.
